Industry
Fractional CRO for Biotech and Life Sciences
Biotech and life-sciences tools sell into scientists, labs and pharma through long, evidence-driven, technical cycles. I have sold into exactly those buyers, and I build the motion for them.
Why life-sciences sales are hard
Your buyers are scientists, lab directors, research institutions and pharma: rigorous, evidence-driven and slow, with procurement, grants and committees in the path. The sale is long, technical and built on credibility, and a generic SaaS motion does not move it.
What I build
- An ICP and message for scientific, research and pharma buyers
- A motion built for long, evidence-driven, technical evaluations
- Reps who can hold a credible scientific and technical conversation
- Partnerships and distribution into labs and institutions
- The pipeline, the forecast and the number, owned end to end
Done in real scientific sales
I sold scientific SaaS into universities, research labs and pharma, writing the scripts and the playbook the reps ran. Selling to the scientific buyer, where the sale is long, technical and built entirely on trust, is something I have actually done.
Common questions
Have you sold to scientific and pharma buyers?
Yes. I sold scientific software into universities, research labs and pharma and built the playbook the reps ran. That credibility-driven, technical sale is exactly this market.
Can you handle long, evidence-driven cycles?
Yes. I build a motion that survives technical evaluation, grants and procurement and keeps long deals moving.
What does a fractional CRO for biotech cost?
Typically $6,000 to $22,000 a month depending on involvement, billed monthly with no lock-in.
Tell me where revenue stalled. I'll tell you why.
A 15-minute call, no pitch. You will leave with at least one concrete thing to fix, whether or not we work together.
Book a 15-Minute Call